ProfileGDS5678 / 1426056_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 7% 7% 7% 7% 7% 9% 11% 7% 7% 7% 7% 7% 7% 7% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 12.159677
GSM967853U87-EV human glioblastoma xenograft - Control 22.144947
GSM967854U87-EV human glioblastoma xenograft - Control 32.144857
GSM967855U87-EV human glioblastoma xenograft - Control 42.095257
GSM967856U87-EV human glioblastoma xenograft - Control 52.100167
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 12.270639
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 22.2990511
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 32.125847
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 42.122937
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 12.140097
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 22.132047
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 32.113487
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 42.132847
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 52.135877